Stock Analysis of Virios Therapeutics Llc (VIRI) - Birds Eye View

1W   2W   1M   3M   1Y   2Y   5Y   
Overview
Code VIRI
Close 0.351
Change -0.0346 / 8.96 %
Volume 867264
Vol Change 806428 / 1325.58 %
IndustryBiotechnology
SectorHealthcare
AIO Strength Index
Technical StrengthBearish
Growth Index Low Growth Stock
Value Index Poor Value Stock
Profitability Index Poor Profitability Stock
Stability Index Excellent Stability


Fundamental View of Virios Therapeutics Llc
PE (TTM)

-1.32

Very Poor
Price / Book

1.53

Good
Price / Sales

0

Very Poor
Piotroski F Score

2.0

Poor
Market Cap

6767.23 K

Enterprise Value

3450.28 K

ROA (TTM)

-104.02

Very Poor
ROE (TTM)

-115.84

Very Poor
Net Margin (TTM)

0

Poor
Revenue

%

0
Net Profit

49.07 %

-6237.40 K
Debt to Equity

0

Excellent
Altman Z Score

-13.18

Very Poor
Quick Ratio

0

Poor
Cash Ratio

9.25

Excellent


Highs/Lows of Virios Therapeutics Llc
PeriodOld priceStock ReturnS&P 500 ReturnsHighLowHigh DateLow Date
One Week0.3549 0.986 % 1.54 % 0.43660.3415-May-2413-May-24
Two Week0.4115 14.61 % 3.42 % 0.46090.33507-May-2410-May-24
One Month0.4509 22.07 % 5.60 % 0.47490.33526-Apr-2410-May-24
Three Month0.3804 7.62 % 5.95 % 0.62880.27922-Mar-2405-Mar-24
Six Months0.739 52.45 % 17.48 % 0.940.27916-Jan-2405-Mar-24
One year1.04 66.21 % 27.52 % 2.420.27914-Jul-2305-Mar-24
Two year4.53 92.24 % 29.70 % 2.420.21914-Jul-2328-Dec-22


Technical View of Virios Therapeutics Llc
RSI

38.19

Neutral
MACD

-0.0192

Bearish
ADX

14.03

Neutral
Super Trend

0.314

Mild Bullish
Williams %R

-86.97

Mild Bullish
CCI

-117.89

Mild Bullish


EMA 5

0.375

Strong Bearish
EMA 15

0.397

Mild Bearish
EMA 50

0.426

Strong Bearish
EMA 100

0.484

Strong Bearish
SMA 100

0.452

Strong Bearish
SMA 200

0.657

Mild Bearish
SMA 5 / 20

0.376 / 0.413

Strong Bearish
SMA 15 / 50

0.404 / 0.423

Strong Bearish
SMA 50 / 200

0.423 / 0.657

Mild Bearish




Charts of Virios Therapeutics Llc


Returns of Virios Therapeutics Llc with Peers
Period / StockVIRIKTTAVVOSSHPH
1 Week-0.986%-14.06%7.76%-4.19%
1 Mth-22.07%-7.69%-13.91%-2.29%
3 Mth-7.62%-8.59%-56.38%5.67%
6mth-52.45%6.42%-43.32%-17.42%
1 Year-66.21%-2.97%-76.82%-63.26%
2 Year-92.24%-65.62%-94.01%-
5 Years----
charts-
View All Together in Chart      Inline           Tile

Compare Fundamentals of Virios Therapeutics Llc with Peers
Ratio / StockVIRIKTTAVVOSSHPH
PE-1.32-0.0020-128.36-0.854
P/B1.530.0004990.271.19
ROA-104.02-20.35-122.79-98.36
ROE-115.84-22.15-771.50-139.87
Debt To Equity00.00351.150.193
Revenue0
% 		486559
0 % 		14503.00 K
9.49 % 		0
%
Net Income-6237.40 K
49.07 % 		-16031.19 K
15.03 % 		-15413.00 K
35.36 % 		-5703.13 K
84.00 %


Technicals of Virios Therapeutics Llc with Peers
Technical / StockVIRIKTTAVVOSSHPH-
ADX14.0313.9833.4117.07
CMF-0.432-0.520-0.00900.289
MFI20.3333.8738.3271.67
RSI38.1940.7040.3646.36
MACD Abv SignalFalseFalseTrueFalse
Price Above 50 MAFalseFalseFalseFalse-
Price Above 200 MAFalseFalseFalseFalse-


About : Virios Therapeutics Llc

Address : 44 Milton Avenue, Alpharetta, GA, United States, 30009
Tel : 866 620 8655
URL : https://www.virios.com
Code : VIRI, ISIN : US92829J1043, Exchange : NASDAQ, Country : USA
Fiscal Year End : December
IPO date : 17_Dec_2020
Employee Count : 4

Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. It also develops IMC-2, a combination of valacyclovir and celecoxib for the treatment of managing the fatigue, sleep, attention, pain, autonomic function, and anxiety associated with long COVID. The company was formerly known as Innovative Med Concepts, LLC and changed its name to Virios Therapeutics, Inc. in July 2020. The company was founded in 2012 and is headquartered in Alpharetta, Georgia.


Note : All Data Generated at the End of Trading Hours (EOD Data)